Mahkam Zanganeh - 16 Aug 2022 Form 4 Insider Report for Summit Therapeutics Inc. (SMMT)

Role
Co-CEO & President, Director
Signature
/s/ Mahkam Zanganeh
Issuer symbol
SMMT
Transactions as of
16 Aug 2022
Net transactions value
+$5,634,858
Form type
4
Filing time
18 Aug 2022, 16:36:42 UTC
Previous filing
10 Jun 2022
Next filing
09 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SMMT Common Stock Purchase $178,897 +184,430 +105% $0.9700 359,969 16 Aug 2022 Direct F1
transaction SMMT Common Stock Purchase $4,455,964 +4,593,777 +186% $0.9700 7,061,557 16 Aug 2022 By the Mahkam Zanganeh Revocable Trust, with the Reporting Person as Trustee. F1, F2
transaction SMMT Common Stock Purchase $999,997 +1,030,925 +49% $0.9700 3,135,466 16 Aug 2022 By the Shaun Zanganeh Irrevocable Trust, with the Reporting Person as Trustee. F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares of Common Stock that the Reporting Person purchased in the Issuer's rights offering.
F2 The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.